Ohana Biosciences has built a proprietary, world-leading sperm biology platform to address significant needs and transform the field of reproductive medicine. Driven by a robust scientific understanding of spermatogenesis and sperm biology, our platform leverages the complexities associated with sperm heterogeneity and function.
Ohana is developing life-changing products that will increase the success rate of assisted reproductive technologies (ARTs); decrease the risk of disease transmission from father to offspring; and provide novel non-hormonal, reversible, long-lasting male contraception.
Ohana was founded in 2016 by Flagship Pioneering and is located in Cambridge, MA.
Working at Ohana
As a dynamic, young, and growing company, we believe
that our team is the strongest asset to achieving our mission.